News | April 24, 2025
Thyrocare Technologies Q4 FY25 consolidated PAT up at Rs. 21.70 Cr
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
Genomics is transforming the future of modern medicine and treatment modalities across specialties
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
Padmanabhan brings over two decades of extensive experience in FMCG sector
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience
GE HealthCare’s Revolution Vibe CT enables more facilities to elevate patient care by offering advanced cardiac imaging technology
Subscribe To Our Newsletter & Stay Updated
